1. Home
  2. JCSE vs GTBP Comparison

JCSE vs GTBP Comparison

Compare JCSE & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCSE
  • GTBP
  • Stock Information
  • Founded
  • JCSE 1999
  • GTBP 1965
  • Country
  • JCSE Singapore
  • GTBP United States
  • Employees
  • JCSE N/A
  • GTBP N/A
  • Industry
  • JCSE Miscellaneous manufacturing industries
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • JCSE Consumer Discretionary
  • GTBP Health Care
  • Exchange
  • JCSE Nasdaq
  • GTBP Nasdaq
  • Market Cap
  • JCSE 7.6M
  • GTBP 4.9M
  • IPO Year
  • JCSE 2022
  • GTBP N/A
  • Fundamental
  • Price
  • JCSE $1.62
  • GTBP $2.15
  • Analyst Decision
  • JCSE
  • GTBP Strong Buy
  • Analyst Count
  • JCSE 0
  • GTBP 1
  • Target Price
  • JCSE N/A
  • GTBP $11.00
  • AVG Volume (30 Days)
  • JCSE 16.2K
  • GTBP 238.1K
  • Earning Date
  • JCSE 10-30-2024
  • GTBP 03-25-2025
  • Dividend Yield
  • JCSE 5.59%
  • GTBP N/A
  • EPS Growth
  • JCSE N/A
  • GTBP N/A
  • EPS
  • JCSE 0.12
  • GTBP N/A
  • Revenue
  • JCSE $14,723,999.00
  • GTBP N/A
  • Revenue This Year
  • JCSE N/A
  • GTBP N/A
  • Revenue Next Year
  • JCSE N/A
  • GTBP N/A
  • P/E Ratio
  • JCSE $13.04
  • GTBP N/A
  • Revenue Growth
  • JCSE N/A
  • GTBP N/A
  • 52 Week Low
  • JCSE $0.60
  • GTBP $1.72
  • 52 Week High
  • JCSE $2.39
  • GTBP $10.66
  • Technical
  • Relative Strength Index (RSI)
  • JCSE 65.83
  • GTBP 42.94
  • Support Level
  • JCSE $1.43
  • GTBP $2.10
  • Resistance Level
  • JCSE $1.71
  • GTBP $2.39
  • Average True Range (ATR)
  • JCSE 0.08
  • GTBP 0.21
  • MACD
  • JCSE 0.02
  • GTBP 0.01
  • Stochastic Oscillator
  • JCSE 85.71
  • GTBP 36.00

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: